Even if the NIH is drastically cut, we don't see a doomsday scenario for these companies, and some of the industry's stronger players are now trading at attractive valuations.
Slowing in some emerging markets likely affects other emerging markets more than it harms the U.S. economy, says Morningstar's Bob Johnson.
As Chinese steel production goes, so do companies like Cliffs Natural Resources.
David Hogan, Client Portfolio Manager for Laudus Mondrian's Emerging Markets Fund sees emerging Asian markets as well positioned for the economic recovery.
©2012 Morningstar Advisor. All right reserved.